Effect of ACAT inhibition on the progression of coronary atherosclerosis.
Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM; ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators.
Nissen SE, et al. Among authors: nicholls sj.
N Engl J Med. 2006 Mar 23;354(12):1253-63. doi: 10.1056/NEJMoa054699.
N Engl J Med. 2006.
PMID: 16554527
Free article.
Clinical Trial.